The clinical and laboratory standards institute document MM16-A provides approved guidelines for the use of external RNA controls in gene expression tests, protocols that support the use of external RNA controls in microarray and QRT-PCR-based gene expression experiments. This guideline addresses key issues regarding the use of external RNA controls as a tool for validation of technical performance and to support the evaluation of qualitative results for a given clinical analyte, including the preparation of control transcripts, the design of primers and amplicons, and quality control.
Use in the final experimental or clinical testing application and analysis and interpretation of obtained data provides protocols that support guidance, research and clinical laboratories, regulatory agencies, accreditation bodies, reference laboratories, as well as the use of external RNA controls in testing, microarray-based gene expression experiments.
EUROLAB assists manufacturers with CLSI MM16-A test compliance. Our test experts, with their professional working mission and principles, provide you, our manufacturers and suppliers, the best service and controlled testing process in our laboratories. Thanks to these services, businesses receive more effective, high-performance and quality testing services and provide safe, fast and uninterrupted service to their customers.
To get an appointment, to get more detailed information or to request an evaluation, you can ask us to fill in our form and reach you.
EUROLABreporting and certification activities, United Accreditation Foundation (UAF), Turkish Accreditation Agency (TÜRKAK) ve Enterprise Accreditation Foundation (EAF) based on the accreditation provided by the accreditation body. The Enterprise Accreditation Foundation (EAF) accreditation body is also a signatory of the United Nations (UN GLOBAL COMPACT) organization.
